Novelix Pharma Reconstitutes Three Board Committees

Novelix Pharmaceuticals Ltd (BSE: 536565) reconstituted its Audit, NRC, and Stakeholders Relationship Committees effective March 30, 2026.
Post-reconstitution, Janardhan Das Kabra chairs the Audit Committee; Sridevi Belide chairs the Stakeholders Relationship Committee.
The filing was made under Regulation 30 of SEBI (LODR) Regulations, 2015, following a Board meeting held on March 30, 2026.